Advances in pharmacogenetics and pharmacogenomics related to CINV should contribute to future personalized cancer therapy strategies.

Dr. Swen is one of the primary investigators of the “Ubiquitous Pharmacogenomics” project (www.upgx.eu). U-PGx aims to implement pharmacogenetics across 7 European sites by genotyping 8,100 ...

The chemotherapy drugs 5-FU and capecitabine could harm or kill you if you have a variant in the DPYD gene. Request genetic testing before you take these drugs.

It explores the role of pharmacogenetics developing an understanding of ... The course aims are to: Provide a detailed knowledge of genetics and pharmacogenomics in medicine. Review the principles and ...

The Clinical Pharmacology and Pharmacogenetics research groups at the Individualized Drug Therapy Research Program (INDIVIDRUG), University of Helsinki, work to identify key factors affecting drug ...

Acute lymphoblastic leukemia (ALL) affects both children and adults, but children have better chances to be cured, with long-term survival rates over 85% compared to 50-75% in adults. Scientists ...

ASHG welcomed eight 2024–2026 Human Genetics Scholars who are recognized for their accomplishments and commitment to fostering DEI in human genetics and genomics.

The American Society of Pharmacovigilance is excited to announce the recipients of the inaugural STRIPE Double Helix Awards, celebrating individuals and organizations that have made exceptional ...

My clinical focuses are in psychopharmacology, pharmacogenetics, and treatment resistant conditions. In addition, I am a member of the American Society of Clinical Hypnosis and provide treatment ...

Advances in pharmacogenetics and pharmacogenomics related to CINV should contribute to future personalized cancer therapy strategies.